During the past decade, Tennessee Oncology, PLLC conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Tennessee Oncology, PLLC" #1 collaborator was "Medivation, Inc." with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Tennessee Oncology, PLLC" are "Ovarian Cancer" (3 trials), "Breast Neoplasms" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Triple Negative Breast Cancer" (2 trials) and "BRCA 1 Gene Mutation" (1 trials). Many other conditions were trialed in "Tennessee Oncology, PLLC" in a lesser frequency.

Most popular intervention types in "Tennessee Oncology, PLLC" are "Drug" (13 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Avelumab" (2 trials), "Carboplatin" (2 trials), "Gemcitabine" (2 trials), "Paclitaxel" (2 trials) and "Sacituzumab Govitecan-hziy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Tennessee Oncology, PLLC" are 9 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Tennessee Oncology, PLLC". undefined are not yet recruiting, 2 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Tennessee Oncology, PLLC, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Tennessee Oncology, PLLC, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".